Diagnostic Evaluation in Aspirin-Exacerbated Respiratory Disease

被引:5
|
作者
Williams, Adam N. [1 ,2 ,3 ]
机构
[1] Bend Mem Clin, Dept Allergy Asthma & Immunol, 815 Southwest Bond St, Bend, OR 97702 USA
[2] Oregon Hlth & Sci Univ, Sch Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA
[3] Bend Mem Clin, 815 Southwest Bond St, Bend, OR 97702 USA
关键词
Aspirin-exacerbated respiratory disease; Diagnosis; NSAID hypersensitivity; Chronic rhinosinusitis with nasal polyps; Asthma; Intranasal ketorolac; Oral aspirin challenge; Lysine-aspirin; PERIPHERAL-BLOOD LEUKOCYTES; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; LEUKOTRIENE-MODIFIER DRUGS; NASAL PROVOCATION TEST; IN-VITRO DIAGNOSIS; INDUCED ASTHMA; SENSITIVE ASTHMATICS; BASOPHIL ACTIVATION; CYSTEINYL LEUKOTRIENES; LYSINE-ASPIRIN;
D O I
10.1016/j.iac.2016.06.003
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Aspirin-exacerbated respiratory disease (AERD) is a distinct clinical condition characterized by chronic sinusitis with nasal polyps, asthma, and hypersensitivity reactions to nonsteroidal anti-inflammatory drugs (NSAIDs). Distinguishing AERD from other forms of chronic sinusitis, asthma, and NSAID reactivity has important clinical implications for management. The clinical history is helpful, but not adequate for confirming the diagnosis of AERD, in most cases. Diagnostic provocation challenge remains the only way to confirm or exclude the diagnosis of AERD. This article discusses the utility of the clinical history and the current evidence regarding measures that optimize the safety of performing diagnostic NSAID provocation challenges.
引用
收藏
页码:657 / +
页数:14
相关论文
共 50 条
  • [1] Aspirin-Exacerbated Respiratory Disease: Evaluation and Management
    Lee, Rachel U.
    Stevenson, Donald D.
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2011, 3 (01) : 3 - 10
  • [2] In vitro diagnostic of aspirin-exacerbated respiratory disease (AERD)
    Dollner, R.
    Hoermann, K.
    Stuck, B. A.
    Pfaar, O.
    Klimek, L.
    ALLERGOLOGIE, 2014, 37 (01) : 11 - 19
  • [3] Aspirin-Exacerbated Respiratory Disease
    Walgama, Evan S.
    Hwang, Peter H.
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2017, 50 (01) : 83 - +
  • [4] Aspirin-exacerbated respiratory disease
    Wangberg, Hannah
    White, Andrew A.
    CURRENT OPINION IN IMMUNOLOGY, 2020, 66 : 9 - 13
  • [5] Aspirin-Exacerbated Respiratory Disease
    White, Andrew A.
    Stevenson, Donald D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (11): : 1060 - 1070
  • [6] Aspirin-exacerbated respiratory disease
    Randerath, W. J.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 (11) : 541 - 546
  • [8] Clinical evaluation and diagnosis of aspirin-exacerbated respiratory disease
    Haque, Rubaiyat
    White, Andrew A.
    Jackson, David J.
    Hopkins, Claire
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 148 (02) : 283 - 291
  • [9] Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease
    White, Andrew A.
    Stevenson, Donald D.
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2013, 33 (02) : 211 - +
  • [10] Dysbiosis in aspirin-exacerbated respiratory disease
    Cook, Kevin A.
    Domissy, Alain
    Simon, Ronald A.
    White, Andrew A.
    Modena, Brian D.
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2021, 11 (07) : 1116 - 1120